| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/19/2013 | US8378064 Hydrophilic polymers as medical lubricants and gels |
| 02/19/2013 | US8378059 Supramolecular handcuffs in polymeric architecture |
| 02/19/2013 | US8377994 Use of roll compacted pyrogenically produced silicon dioxide in pharmaceutical compositions |
| 02/19/2013 | US8377992 TRBD-binding effectors and methods for using the same to modulate telomerase activity |
| 02/19/2013 | US8377991 Trans-clomiphene for metabolic syndrome |
| 02/19/2013 | US8377990 Conjugates comprising a psychotropic drug or a GABA agonist and an organic acid and their use in treating pain and other CNS disorders |
| 02/19/2013 | US8377989 Room temperature stable non-crystalline aspirin and method for the preparation thereof |
| 02/19/2013 | US8377988 Use of L-carnitine or of alkanoyl L-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye drops |
| 02/19/2013 | US8377987 Compounds and uses thereof for treating inflammation and modulating immune responses |
| 02/19/2013 | US8377986 Amino acid derivatives |
| 02/19/2013 | US8377985 Treatment of cancer |
| 02/19/2013 | US8377984 Substituted gamma lactams as therapeutic agents |
| 02/19/2013 | US8377983 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors |
| 02/19/2013 | US8377982 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 02/19/2013 | US8377981 CBI derivatives subject to reductive activation |
| 02/19/2013 | US8377980 Hepatitis C virus inhibitors |
| 02/19/2013 | US8377978 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors |
| 02/19/2013 | US8377977 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
| 02/19/2013 | US8377976 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 02/19/2013 | US8377975 Oxadiazole derivatives for the treatment of diabetes |
| 02/19/2013 | US8377974 Factor Xa inhibitors |
| 02/19/2013 | US8377973 Compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations |
| 02/19/2013 | US8377972 Use of quaternary pyridinium compounds for vasoprotection and/or hepatoprotection |
| 02/19/2013 | US8377971 Non-flushing niacin analogues, and methods of use thereof |
| 02/19/2013 | US8377970 Modulators of calcium release-activated calcium channel |
| 02/19/2013 | US8377969 Compounds for use in the treatment of cancer |
| 02/19/2013 | US8377968 N-piperidinyl acetamide derivatives as calcium channel blockers |
| 02/19/2013 | US8377967 Piperidine derivative |
| 02/19/2013 | US8377966 Biphenyl compounds useful as muscarinic receptor antagonists |
| 02/19/2013 | US8377965 Crystalline forms of a biphenyl compound |
| 02/19/2013 | US8377964 Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists |
| 02/19/2013 | US8377963 Insulin-regulated aminopeptidase (IRAP) inhibitors and uses thereof |
| 02/19/2013 | US8377962 Macrocyclic serine protease inhibitors |
| 02/19/2013 | US8377961 Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and P53 |
| 02/19/2013 | US8377960 Inhibitors of human immunodeficiency virus replication |
| 02/19/2013 | US8377959 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 02/19/2013 | US8377958 Lonidamine analogues for fertility management |
| 02/19/2013 | US8377957 Hydroxy and alkoxy substituted 1H-imidazoquinolines and methods |
| 02/19/2013 | US8377956 Use of (3R)-4-{[(1S)-2-methyl-1-(2-methylpropanoyloxy)propoxy]carbonylamino}-3-(4-chlorophenyl) butanoic acid for treating urinary incontinence |
| 02/19/2013 | US8377955 Branched 3- and 6-substituted quinolines as CGRP receptors antagonists |
| 02/19/2013 | US8377954 Bicyclic spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease |
| 02/19/2013 | US8377953 Isothiazole and pyrazole derivatives as fungicides |
| 02/19/2013 | US8377952 Solid pharmaceutical dosage formulation |
| 02/19/2013 | US8377951 Transdermal administration of phycotoxins |
| 02/19/2013 | US8377950 Crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt |
| 02/19/2013 | US8377949 Quinazolinedione chymase inhibitors |
| 02/19/2013 | US8377948 Antitumor agents and methods of their use |
| 02/19/2013 | US8377947 Treating alzheimer's disease and osteoporosis and reducing aging |
| 02/19/2013 | US8377946 Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors |
| 02/19/2013 | US8377945 Small molecule inhibitors of spleen tyrosine kinase (SYK) |
| 02/19/2013 | US8377944 Thienopyrimidine derivatives |
| 02/19/2013 | US8377943 2,4-diaminopyrimidine derivates as PTK2-inhibitors for the treatment of abnormal cell growth |
| 02/19/2013 | US8377942 Isoxazolines derivatives and their use as pesticide |
| 02/19/2013 | US8377941 Indoles as modulators of nicotinic acetylcholine receptor subtype alpha-7 |
| 02/19/2013 | US8377940 Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators—842 |
| 02/19/2013 | US8377939 Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators 842 |
| 02/19/2013 | US8377938 Phenoxypyridine derivative salts and crystals thereof, and process for preparing the same |
| 02/19/2013 | US8377937 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
| 02/19/2013 | US8377936 Nicotinic receptor agonists for the treatment of inflammatory diseases |
| 02/19/2013 | US8377935 Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase |
| 02/19/2013 | US8377934 Use of stilbene derivatives for treatment and prevention of aquatic mold infections |
| 02/19/2013 | US8377933 Method for treating a pulmonary hypertension condition |
| 02/19/2013 | US8377932 Preparation of 1-(substituted benzyl)-5-trifluoromethyl-2(1H)pyridone compounds and salts thereof and their applications |
| 02/19/2013 | US8377931 Benzoxazine derivatives and uses thereof |
| 02/19/2013 | US8377930 PDE10 inhibitors and related compositions and methods |
| 02/19/2013 | US8377929 Crystalline forms of the tri-mesylate salt of perphenazine-GABA and process of producing the same |
| 02/19/2013 | US8377928 3-aminosulfonyl substituted indole derivatives and methods of use thereof |
| 02/19/2013 | US8377927 Compositions and methods for treatment of cancer |
| 02/19/2013 | US8377926 Aminopyridine kinase inhibitors |
| 02/19/2013 | US8377925 Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor |
| 02/19/2013 | US8377924 Protein kinase C inhibitors and uses thereof |
| 02/19/2013 | US8377923 Triazole derivative or salt thereof |
| 02/19/2013 | US8377922 Benzazepinone compound |
| 02/19/2013 | US8377921 Compounds and compositions as protein kinase inhibitors |
| 02/19/2013 | US8377920 Methods of treating hypertriglyceridemia |
| 02/19/2013 | US8377919 Therapeutic compositions |
| 02/19/2013 | US8377917 Polymeric prodrug with a self-immolative linker |
| 02/19/2013 | US8377916 Steroids as agonists for FXR |
| 02/19/2013 | US8377915 Methods for treating or preventing disorders using ecdysteroid compositions |
| 02/19/2013 | US8377914 Method of inducing negative chemotaxis |
| 02/19/2013 | US8377913 Vitamin D receptor activators and methods of making |
| 02/19/2013 | US8377912 Preparation for the prevention and/or treatment of vascular disorders |
| 02/19/2013 | US8377911 Diuretics |
| 02/19/2013 | US8377910 Immunoregulator compounds |
| 02/19/2013 | US8377909 Use of phytate as agent inhibiting dissolution of crystals of calcium salts for the prevention of osteoporosis |
| 02/19/2013 | US8377908 Fixed-dose association of phytate and zinc |
| 02/19/2013 | US8377907 Compositions for treating alcohol hangover |
| 02/19/2013 | US8377906 Compositions and methods for preventing or reducing postoperative ileus and gastric stasis |
| 02/19/2013 | US8377905 Stable crystal of 1-(2′-cyano-2′-deoxy-β-D-arabinofuranosyl)cytosine monohydrochloride |
| 02/19/2013 | US8377904 preventing cartilage degradation in animals, using a combination of a sulfur containing amino acid and manganese |
| 02/19/2013 | US8377903 Cladribine regimen for treating multiple sclerosis |
| 02/19/2013 | US8377902 RNAi compound targeted to thrombospondin-1 and applications thereof |
| 02/19/2013 | US8377897 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 02/19/2013 | US8377896 Antibacterial 4,6-substituted 6′, 6″ and 1 modified aminoglycoside analogs |
| 02/19/2013 | US8377895 Cyclin-dependent protein kinases inhibitors of Scutellaria flavonoid organic amine derivatives, synthesis and use thereof |
| 02/19/2013 | US8377894 Drug and food or drink for improving pancreatic functions |
| 02/19/2013 | US8377893 Highly purified antiendotoxin compound |
| 02/19/2013 | US8377892 Use of alkyl glycosides as agents for inhibiting microbial growth and compositions containing them |
| 02/19/2013 | US8377886 Use of gamma secretase inhibitors and notch pathway inhibitors for treatment and prevention of renal disease |
| 02/19/2013 | US8377878 Therapies for chronic renal failure |